Surgical Air Disinfection Market Global Report 2026

The surgical air disinfection market size has grown strongly in recent years. It will grow from $0.49 billion in 2025 to $0.52 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to growing incidence of hospital acquired infections, increasing investment in operating room infrastructure, rising awareness of infection prevention practices, expanding healthcare facility modernization, increasing demand for sterile surgical environments.

The surgical air disinfection market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growing demand for advanced air purification systems, rising investments in smart healthcare infrastructure, increasing emphasis on indoor air quality standards, expanding surgical procedure volumes, growing focus on patient safety and healthcare facility efficiency. Major trends in the forecast period include increasing adoption of advanced air sterilization systems in operating rooms, growing focus on surgical site infection prevention, rising demand for continuous air quality management in healthcare facilities, expanding deployment of high-capacity air purification technologies, increasing preference for multi-technology air disinfection solutions.

The increasing volume of surgical procedures is projected to drive the growth of the surgical air disinfection market in the forecast period. Surgical procedures are medical interventions conducted by skilled surgeons using specialized tools and methods to diagnose, treat, restore, or remove diseased, injured, or abnormal tissues and organs within the body. The rising incidence of chronic diseases, such as cardiovascular diseases, cancer, orthopedic disorders, and obesity, is driving the growth of elective and emergency surgical procedures globally. This increase in surgical activity is creating demand for advanced surgical air disinfection systems to control airborne contaminants, lower the risk of surgical site infections (SSIs), and preserve sterile conditions in operating rooms. For instance, in May 2026, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government health research agency, hospitalizations involving surgical procedures reached 3.1 million in 2024-25, representing 24% of total hospitalizations. During the same period, emergency hospitalizations involving surgical procedures increased by 1.1% from 384,000 in 2023-24 to 398,000 in 2024-25. Therefore, the increasing number of surgical procedures is supporting the growth of the surgical air disinfection market.

Leading companies operating in the surgical air disinfection market are focusing on developing advanced operating room air purification and ventilation technologies, such as Temperature-controlled AirFlow (TcAF) technology, to enhance infection prevention, improve airborne contamination control, and maintain ultra-clean surgical environments. Temperature-controlled AirFlow (TcAF) technology is an advanced airflow management approach that uses controlled temperature differences to regulate the movement and distribution of clean air within operating rooms, creating a stable ultra-clean zone around the surgical site while reducing the spread of airborne contaminants. For example, in September 2024, Avidicare, a Sweden-based medical technology company specializing in operating room air quality solutions, launched Opragon 4, an advanced operating room ventilation system designed to provide controlled ultra-clean airflow in surgical environments. The system uses Avidicare’s patented Temperature-controlled AirFlow (TcAF) technology to reduce airborne contaminants, improve infection prevention, and maintain safer operating room conditions for patients and surgical staff.

In April 2026, Aerobiotix, a US-based healthcare technology company focused on advanced air purification and infection prevention solutions, entered into a partnership with Premier Inc. through Premier’s Technology Breakthrough Designation program to increase access to the Illuvia Sense continuous air disinfection system in hospitals and surgical facilities. This collaboration allows Premier member healthcare organizations to utilize Aerobiotix’s operating-room air purification solution, which integrates HEPA filtration, ultraviolet germicidal (UV-C) technology, and real-time air quality monitoring to minimize airborne contaminants and enhance infection prevention measures in surgical settings. Premier Inc. is a US-based healthcare performance improvement organization.

Major companies operating in the surgical air disinfection market report are Abatement Technologies Inc., Aerobiotix Inc., Aerus LLC (ActivePure Technologies), Airgle Corporation, American Ultraviolet, Biomoneta, Clean Air Group Inc., Inivos, ISO-Aire LLC, RGF Environmental Group Inc., Sanuvox Technologies Inc., UltraViolet Devices Inc. (UVDI), UV Resources, WellAir.

North America was the dominant region in the surgical air disinfection market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the surgical air disinfection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the surgical air disinfection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.